F. Vyth-Dreese

Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19

J. Sein, A. Hekman, C. Melief, 2005, Cancer Immunology, Immunotherapy.